Paragonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix expands board to support rapid commercial growth in the heart transplant market CAMBRIDGE, MASSACHUSETTS, June 22, 2020- Paragonix Technologies, Inc. a commercial stage company and leader in organ preservation…

Continue ReadingParagonix Technologies Announces Appointment of Alexander K. Arrow, MD, CFA to the Board of Directors

Paragonix Technologies Announces Enrollment Milestone for its Global Registry for Donor Heart Preservation

The Paragonix GUARDIAN Registry has reached its 100th patient enrollment milestoneCAMBRIDGE, MASSACHUSETTS, June 2, 2020- Paragonix Technologies, Inc. today announced that its clinical global registry, the Global Utilization And Registry…

Continue ReadingParagonix Technologies Announces Enrollment Milestone for its Global Registry for Donor Heart Preservation